JESFC 2027 — Contrôle scientifique de la répartition des communications

Document de validation à destination du comité scientifique — répartition automatique Communications Orales (CO) / Sessions HUB, générée à partir des notations et de la grille de programmation. Survolez un titre pour lire l'abstract complet ; utilisez le menu « Déplacer » en bout de ligne pour changer un abstract de session.

632abstracts soumis
409note ≥ 13
120en communication orale
276en session HUB
396total programmé
18non retenus (capacité)
5repêchés (<13)
Méthodologie : seuls les abstracts notés ≥ 13 sont éligibles. Le nombre de sessions et leur taille (max 8 en communication orale, max 12 en HUB) suivent la grille de programmation transmise ; dans chaque thème, les meilleures notes sont affectées aux communications orales, le tri par titre au sein d'une session servant à regrouper les abstracts proches thématiquement (sous-thème indiqué). Quand la grille prévoit plus de places que d'abstracts éligibles, les meilleurs abstracts sous le seuil sont repêchés. Quand elle en prévoit moins, les abstracts les moins bien notés ne sont pas retenus. Les titres soulignés en pointillés affichent l'abstract complet au survol de la souris ; le menu « Déplacer » de chaque ligne permet de changer un abstract de session (surligné en vert dans sa nouvelle session).
Vos validations sont enregistrées automatiquement au fur et à mesure : il n'y a rien à envoyer. Les boutons « Résumé » (relire vos décisions d'un coup d'œil) et « Exporter mes validations (JSON) » (sauvegarde de secours sur votre ordinateur) restent disponibles si besoin.
Vos annotations sont enregistrées automatiquement dans ce navigateur.

01 - Maladie coronaire

78soumis
50note ≥ 13
16en comm. orale
34en HUB
50total programmé

Communications orales

CO Jeudi — Session 1 (8/8 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-39416.00Antegrade versus retrograde strategies in chronic total occlusion percutaneous coronary intervention: impact of lesion complexity on procedural outcomesW. Hamdi
2JESFC27-62516.00Clinical phenotypes of patients with chronic coronary syndromesJ. Mesnier
3JESFC27-61015.75Combined automated CAD-RADS and CT-FFR analysis for improved CTO detectionV. Pham
4JESFC27-34816.33Distal Coronary Pressure Profile in Chronic Total Occlusions: A Single-Center Descriptive Study of 119 Patients — Reference Values, Clinical Determinants, and Implications for PracticeA. Mounssif
5JESFC27-40116.33Early Post-Infarction Hyperthermia Is Associated With Adverse Outcomes After STEMIA. Hayek
6JESFC27-21917.00Evaluation of a novel angiographic measure of coronary atheroma burden as a predictor of periprocedural events after elective percutaneous coronary intervention: The ALPHEUS-ATHEROMA Score StudyT. Pommier
7JESFC27-03515.67FOCUS-CMR: An Ischemia-Driven Strategy to Improve Accessibility of Stress CMR in Real-World PracticeZ. Chati
8JESFC27-65515.75Impact of anthropometric parameters in patients with chronic coronary syndromesJ. Mesnier
CO Vendredi — Session 1 (8/8 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-20816.33Impact of immediate high-intensity statin with or without ezetimibe on lipid goal achievement and early clinical outcomes after acute coronary syndrome: a randomized prospective Tunisian studyH. Touati
2JESFC27-05215.67Ischemia, Not Scar, Drives Outcomes: Incremental Prognostic Value of the Myocardial Ischemia and Scar Integrated Index (MISSI) on Stress CMRZ. Chati
3JESFC27-02515.67Long-Term Outcomes of Stepwise Provisional Versus Upfront Two-Stent PCI for True Distal Left Main Bifurcation Lesions: A Single-Center Registry StudyY. Toukami
4JESFC27-03616.00MISSI: A Structured Stress CMR Phenotyping Approach to Predict Coronary RevascularizationZ. Chati
5JESFC27-21516.00P2Y12 Inhibition by Ticagrelor or Clopidogrel and Associated Periprocedural Outcomes in Patients Undergoing Elective Coronary Stenting: The BIO-ALPHEUS StudyB. Lattuca
6JESFC27-85515.67Prognostic Impact of Reduced Right Ventricular Strain in Inferior STEMIE. Allouche
7JESFC27-38016.67REBOOTED-RW - Effectiveness of beta-blockers after myocardial infarction without heart failure: a nationwide target emulation trialA. Delapierre
8JESFC27-65816.25Tocilizumab is associated with a lower incidence of major adverse cardiovascular events in Giant Cell ArteritisA. F. Guédon

Sessions HUB

HUB Mercredi — Session 1 (12/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-35013.33A Peripheral Center, A Central Role: 12-Year Coronary Rotablation Experience in Brittany (305 Cases)N. Laktib
2JESFC27-82115.00Acute Coronary Syndromes (ACS) in young adults in a sub-Saharan African population: Are there differences between men and women?A. Ekou
3JESFC27-64615.50Can low-risk STEMI patients be safely discharged within 48 hours after primary PCI? Insights from a prospective randomized studyW. Dahmane
4JESFC27-85313.67Cardiovascular risk factors in acute coronary syndromes : trends over 10 years (2013-2022) in a sub-Saharan Africa PopulationH. Yao
5JESFC27-46315.00Clinical Outcomes and Determinants of Management Strategy in Delayed Presentation Myocardial Infarction: A Two Year Retrospective Cohort StudyI. El hauat
6JESFC27-50314.75Coronary Rotablation in Elderly Women: A Specific Risk Profile and Procedural OutcomesW. Ait Moha Ou Haddou
7JESFC27-60114.50Diagnostic Performance of a Fully Automated On-Site AI-Based CT-Derived Fractional Flow Reserve in a Multicenter Real-World CohortV. Pham
8JESFC27-81615.33Early LDL C Target Attainment After Acute Coronary Syndrome: Superiority of Upfront Atorvastatin 40 mg Plus Ezetimibe 10 mg Over High Dose Atorvastatin Monotherapy in a Tunisian CohortH. Touati
9JESFC27-81115.00Gender differences in cardiovascular risk profile and disease severity in acute coronary syndromesC. Aboueddahab
10JESFC27-84713.25Hyperuricemia: A Predictor of New-Onset Atrial Fibrillation in a Tunisian Population with Acute Coronary SyndromeM. Ben Halima
11JESFC27-57914.75Impact of a structured multidisciplinary secondary prevention unit on treatment intensification and risk factor control after first acute coronary syndromeI. Kammoun
12JESFC27-09413.50Inferior myocardial wall ischemia (IMWI) score: how to improve multi-pinhole CZT myocardial perfusion imaging specificity for IMWIF. Vauchot
HUB Jeudi — Session 1 (11/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-21615.00Inflammation and Periprocedural Myocardial Injury in Elective PCI: Insights from the ALPHEUS Randomized TrialT. Pommier
2JESFC27-80813.00Inflammatory Indices in Acute Coronary Syndrome: Links to Acute Features and Prognostic Value at 6 MonthsH. Touati
3JESFC27-83115.00Invasive versus conservative management of NSTEMI in the elderly: a bicentric study on clinical outcomes and 12-month prognosisE. Allouche
4JESFC27-07114.67Ischemia Means Something Different in Women Across Age: Sex-Specific Prognostic Impact and Non-Linear Patterns on Stress CMRZ. Chati
5JESFC27-82713.67Ischemic and bleeding risk profiles in patients with myocardial infarction undergoing percutaneous coronary intervention: a Tunisian real-world studyF. El Ayech Boudiche
6JESFC27-87514.00Long term prognostic value of silent myocardial ischaemia in asymptomatic people with HIVF. Boccara
7JESFC27-31214.00Management of DES coronary restenosis in a real-life setting with a three-year outcomeF. Boukerche
8JESFC27-23013.33Multidisciplinary structured screening for silent coronary artery disease in high-risk diabetic patients: a prospective real-world studyW. Dahmane
9JESFC27-26015.00Myocardial Work In Non-St-Elevation Myocardial Infarction: A Novel Approach To Assess Coronary Lesion SeverityS. Jeridi
10JESFC27-07213.67Neutrophil-to-Lymphocyte Ratio as a Marker for Cardiovascular Risk StratificationK. Louay
11JESFC27-46713.67Psychological Distress and Atherogenic Dyslipidemia: Association Between Depression and Triglyceride ElevationY. Ayadi
HUB Vendredi — Session 1 (11/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-28315.33Residual Cardiovascular Risk After Contemporary Drug-Eluting Stent PCI: A Pragmatic Stratification ApproachB. Mlik
2JESFC27-25014.67Retinal OCT-A as a Window on Residual Risk: Five-year Outcomes after Acute Coronary SyndromeA. Esteves
3JESFC27-87213.33Retrograde Percutaneous Coronary Intervention for Chronic Total Occlusions: Technical Insights and In hospital Procedural OutcomesM. Louati
4JESFC27-19415.33Risk profile in ACS in young women: contribution of Lp(a) measurement: ancillary analysis of the WAMIF studyS. Manzo-Silberman
5JESFC27-47314.25Rotablator dans les syndromes coronariens aigus versus chroniques : analyse comparative d’une cohorte bretonne de 305 patientsW. Ait Moha Ou Haddou
6JESFC27-03714.00Serial Stress CMR Enables Dynamic Risk Stratification in Coronary Artery DiseaseZ. Chati
7JESFC27-79314.33Short‑Term Tolerability and Clinical Outcomes of Intensive Lipid‑Lowering Strategies After Acute Coronary Syndrome (ACS): Insights from a Tunisian Randomized TrialH. Touati
8JESFC27-81513.67The burden of recurrence: independent predictors of repeat acute coronary syndrome in a real-world cohortA. Chetoui
9JESFC27-53315.33Timing of coronary angiography and clinical outcomes in NSTEMIC. Belafia
10JESFC27-81813.67Trends in STEMI Reperfusion Strategies and Management Delays Over Six Years in a Reference Tunisian CenterS. Boudiche
11JESFC27-37413.33When the Ear Hears the Heart's Cry: Frank's Sign, Cardiovascular Risk Factors, and Coronary Lesion LocationN. Laktib

02 - Insuffisance cardiaque et cardiomyopathies

125soumis
75note ≥ 13
24en comm. orale
33en HUB
57total programmé
⚠ 18 abstract(s) éligible(s) non retenu(s) par manque de place (capacité limitée par la grille de programmation).

Communications orales

CO Mercredi — Session 1 (8/8 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-14315.33A novel biomarker for HCM prognosis stratification – GDF-15, from a prospective cohort with long term follow-upP. NG
2JESFC27-60815.67Apical hypertrophic cardiomyopathy: particularities and study of myocardial deformationR. Pavier
3JESFC27-60416.67Association of SGLT2 inhibitors and New-Onset Dementia in Non-Diabetic Patients with Heart FailureA. Hacil
4JESFC27-55916.67Beyond geography: one remote monitoring program, two Frances in heart failure careA. Monfort
5JESFC27-69816.33Cardiac amyloidosis in heart failure with preserved ejection fraction: frequency and diagnostic approachS. Antit
6JESFC27-06916.67Cardiac presentation and treatment response by sex in patients with transthyretin amyloidosis: Pooled analysis of vutrisiran and patisiran Phase 3 studiesA. Zaroui
7JESFC27-66417.00Cardiovascular manifestations and care pathway of ATTR and AL amyloidosis in France: a nationwide database studyO. Pereira
8JESFC27-68016.33CECICS: From a National Heart Failure Cooperation Protocol to Nationwide Implementation of an Integrated Care Model in FranceT. Damy
CO Jeudi — Session 1 (8/8 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-06418.33Circulating Transthyretin as an Independent Systemic Vulnerability Signal in Transthyretin Amyloidosis: Insights From the French HEAR RegistryA. Zaroui
2JESFC27-32915.33Data driven machine learning model for long-term mortality prediction in Takayasu ArteritisA. Kante
3JESFC27-58917.00Determinants of SGLT2 Inhibitor Non-Prescription at Discharge After Heart Failure Hospitalisation in Very Old Adults: A Real-World Cardiogeriatric StudyR. Esser
4JESFC27-84217.00Evaluation of pathogenic intermediate effect variant in Hypertrophic cardiomyopathy: impact in familial management and cascade screeningM. Lodin-Pasquier
5JESFC27-53617.00Evaluation of the yield index of genetic counselling for first-degree relatives of patients with hereditary transthyretin cardiac amyloidosisB. Hebrard
6JESFC27-22116.33Feasibility and impact of home-based cardiac rehabilitation using wearable monitoring in a low-resource settingM. Ztati
7JESFC27-37316.00Heart Failure and Sexual Health: Gender-Specific Impacts and Unmet Needs in the ROMANTIC Study*M. Villaceque
8JESFC27-07018.00Long-Term Vutrisiran Reduces Cardiovascular Events and Hospitalizations in Patients with Transthyretin Cardiac Amyloidosis in the HELIOS-B One-Year Open Label ExtensionO. Lairez
CO Vendredi — Session 1 (8/8 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-50417.50Prognosis after heart transplantation in patients with laminopathyG. Giordano
2JESFC27-49515.67Relative efficacy of acoramidis, tafamidis and vutrisiran in patients with transthyretin amyloid cardiomyopathy: a multilevel network meta-regressionA. Jobbé Duval
3JESFC27-15715.67Routine etiological testing in acute myocarditis : diagnostic and pronostic valueA. Torregrossa
4JESFC27-35716.00Sex-Related Differences in Characteristics and Outcome of Patients with Acute Myocarditis: Insights From the Prospective MyocarditIRM StudyM. Proust
5JESFC27-62716.00Subclinical Myocardial Dysfunction After Severe Acute Kidney Injury: A Prospective Cardiorenal Cohort StudyN. Florens
6JESFC27-80716.50Sudden cardiac death and major arrhythmic events in patients with Fabry disease: risk stratification in the FHFc multicenter studyY. Temmar
7JESFC27-08815.67The 'HeartMate 6' Strategy: First Multicenter French Experience of Simultaneous Biventricular HeartMate 3 Implantation as Bridge-to-Transplant in End-Stage Biventricular FailureA. Buschiazzo
8JESFC27-73417.33The clinical "V" of heart-failure decompensation: real-world evidence from 66,850 remote-monitoring alertsO. Hanon

Sessions HUB

HUB Mercredi — Session 1 (11/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-44615.002D-strain echocardiography for risk stratification in Desmoplakin cardiomyopathyA. Dupart
2JESFC27-80114.00Accelerated Functional Ageing in Wild-Type Transthyretin Cardiac AmyloidosisO. Lairez
3JESFC27-19214.67Acoramidis improves NYHA class at month 30 versus placebo in patients with ATTRCM: results from the attribute-cm studyN. Zaroui
4JESFC27-06214.50Age-Dependent Sex Differences and Treatment-Associated Outcomes in Transthyretin Wild-Type Cardiac Amyloidosis: A Nationwide Multicenter StudyA. Zaroui
5JESFC27-55614.50Association of telemonitoring with Satelia® Cardio with all-cause mortality across access-to-care indicatorsP. Jourdain
6JESFC27-55414.50Association of telemonitoring with Satelia® Cardio with all-cause mortality in heart failure patients across types of care centreN. Girerd
7JESFC27-43114.00Bridging the Gap Between Conventional Echocardiography and Advanced Imaging in Cardiac Sarcoidosis: The Emerging Role of Strain ImagingE. Ben Brahim
8JESFC27-55314.33Cardiogeriatric Phenotypes of Heart Failure According to Left Ventricular Ejection Fraction in Very Old Adults: The FEVG-CARDIOGER StudyR. Esser
9JESFC27-17214.67Cardiogeriatric Predictors of Early Adverse Outcomes After Heart Failure Hospitalisation in Older Adults: Insights From the Elder-SAT CohortR. Esser
10JESFC27-17115.00CARE-HOME-HF: Integrated cardiogeriatric management of heart failure in long-term care facilitiesR. Esser
11JESFC27-62114.33Clinical and echocardiographic predictors of severe sleep apnea hypopnea syndrome in chronic heart failureS. Romdhane
HUB Jeudi — Session 1 (11/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-39814.67Differences in Survival Outcomes and LVEF of Self-expanding versus Balloon Expandable Valves After TAVI in Patients With Severe Cardiac DysfunctionA. Matta
2JESFC27-60214.67Effect of SGLT2 Inhibitors on Cognitive Function in Elderly Patients with Heart Failure: A Comparative Prospective StudyA. Hacil
3JESFC27-05614.67Epidemiology, outcomes and hospital-based management of obstructive hypertrophic cardiomyopathy in FranceP. Réant
4JESFC27-16115.00Evaluation of aficamten or beta-blocker monotherapy versus placebo in patients with obstructive hypertrophic cardiomyopathy: a pooled analysis of SEQUOIA-HCM and MAPLE-HCMA. Hagège
5JESFC27-16214.33Evolution of cardiopulmonary exercise testing parameters after left ventricular assist device implantationS. Samouk
6JESFC27-06315.33Evolving Genetic Landscape of Hereditary Transthyretin Amyloidosis in France: Nationwide Evidence of a Shift Toward Late-Onset Cardiac VariantsA. Zaroui
7JESFC27-64815.00Exercise adaptation under mavacamten in obstructive hypertrophic cardiomyopathy: insights from real-world cardiopulmonary exercise testingJ. Broustaille
8JESFC27-06715.00Impact of cold ischemic time on vasoactive support requirements following heart transplantation with HTK preservationT. M. Nguyen
9JESFC27-55714.67Impact of diabetes, heart-failure etiologies, comorbidities and short-term weight variability on survival in a national telemonitored heart-failure cohortP. Valensi
10JESFC27-01214.00Influence of vutrisiran on systolic blood pressure in ATTR-CM: HELIOS-BV. Algalarrondo
11JESFC27-69714.00Long-Term Clinical Outcomes in Heart Failure Patients With Preserved Versus Reduced Left Ventricular Ejection Fraction Followed in a Specialized Ambulatory Heart Failure CenterE. J. Ouzan
HUB Vendredi — Session 1 (11/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-80314.50Malnutrition, Circulating Transthyretin Levels, and Prognosis in Transthyretin Cardiac AmyloidosisO. Lairez
2JESFC27-60715.33Management of Loop Diuretics in Very Old Patients Hospitalized for Acute Heart Failure: A Comparison of Geriatric and Cardiology WardsA. Hacil
3JESFC27-51815.00Primary cardiac sarcoidosis is associated with more severe presentation and poorer outcomes than secondary cardiac involvementX. Pinus
4JESFC27-36215.33Prospective Systematic Screening for Transthyretin Amyloid Cardiomyopathy in Cardiology Inpatients With Left Ventricular Hypertrophy: The IMPACT StudyM. Proust
5JESFC27-52815.00Protective effects of extracellular vesicles in a heart failure with preserved ejection fraction–emulating cardiac microtissue modelC. Mathioudaki
6JESFC27-36614.33Quantitative Assessment of Valvular Thickening by Echocardiography as a Marker of Transthyretin Cardiac AmyloidosisM. Proust
7JESFC27-24214.67Redefining Cardiac Screening in Systemic Sarcoidosis: Clinical and Echocardiographic Predictors of Subclinical Myocardial InvolvementR. Harbaoui
8JESFC27-19615.00Serial Transthyretin Monitoring Captures Disease Trajectory and Predicts Survival in Cardiac AmyloidosisM. Kharoubi
9JESFC27-01914.00The Madrid Score in Dilated Cardiomyopathy: Current Evidence and Clinical ApplicationL. Albadiech
10JESFC27-60014.00Towards longitudinal at-home cardiac surveillance: population-scale PEP and LVET from a connected weighing scale, with a path to transthoracic ICGB. Carreel
11JESFC27-14114.67Treatment with transthyretin-lowering RNA interference therapeutics is not associated with ocular or other clinical events due to vitamin A reduction: Pooled analysis of vutrisiran and patisiran dataV. Algalarrondo

03 - Echocardiographie et imagerie

55soumis
26note ≥ 13
16en comm. orale
10en HUB
26total programmé

Communications orales

CO Jeudi — Session 1 (8/8 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-16618.00Association between sex and prognostic value of Late Gadolinium Enhancement Granularity in Hypertrophic Cardiomyopathy: A Cardiovascular Magnetic Resonance StudyF. Abadie
2JESFC27-23815.00Atrial Strain: an Early Marker of Diastolic Impairment in Severe Pediatric ObesityR. Ghenghea
3JESFC27-21116.67Clinical Implications of Late Gadolinium Enhancement in Patients with Active Cancer undergoing Stress CMRT. Goncalves
4JESFC27-70514.67Diagnostic Accuracy of Non-Invasive Myocardial Work for Detecting Coronary Artery Disease and Its Correlation with Angiographic SeverityS. Antit
5JESFC27-79515.67Diagnostic and prognostic value of transthoracic coronary Doppler for the detection of no-reflow after ST-elevation myocardial infarctionY. Bououdina
6JESFC27-70215.00Heart failure with preserved ejection fraction: prognostic value of left atrial stiffness indexS. Antit
7JESFC27-44716.33Improvement of size, shape but not RV function with Sotatercept in pulmonary arterial hypertension: Insights from the largest real-life echocardiographic studyM. El Blidi-Rahmani
8JESFC27-50915.00Integrating right ventricular–pulmonary coupling and venous congestion to predict outcomes in acute heart failureF. Ben Ghorbel
CO Vendredi — Session 1 (8/8 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-82515.67Left atrial mechanical efficiency as a novel parameter to reflect congestion burden and predict outcome in heart failure with reduced and mildly reduced ejection fractionD. I. Vasile
2JESFC27-23515.50Perioperative Assessment of Myocardial Work in Children Undergoing Ventricular Septal Defects ClosureR. Ghenghea
3JESFC27-25316.67Prognostic Value of Persistent LGE in Myocarditis: Clinical and Cardiac MRI Follow-Up at 5 YearsJ. Monniello
4JESFC27-76215.33Right ventricular strain impairment in pediatric asthma: evidence of subclinical myocardial involvementH. Amamou
5JESFC27-41414.67Right Ventricular–Pulmonary Arterial Coupling and Short-Term Prognosis in Heart Failure with Reduced Ejection FractionI. Mtiri
6JESFC27-32516.00Stress CMR phenotyping across systemic diseases: ischemic burden and prognostic implications of late gadolinium enhancementA. Kante
7JESFC27-76815.00Transcranial Doppler as a Non-Invasive Screening Tool for Right-to-Left Shunt Detection in ESUS Patients: Diagnostic Performance Compared to Transesophageal EchocardiographyF. Yahia
8JESFC27-70415.33VExUS score as a prognostic tool in acute heart failure: Association with renal dysfunction, readmission, and mortalityS. Antit

Sessions HUB

HUB Mercredi — Session 1 (10/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-14214.33AI-Assisted Handheld Echocardiography Integrated into Hospital Digital Workflow for Bedside Cardiac Triage: The OPTIMUST Implementation StudyM. Paineau
2JESFC27-32313.67Global longitudinal strain outperforms high-sensitivity troponin for predicting anatomical coronary severity assessed by SYNTAX score in NSTEMIG. Ben Hassen
3JESFC27-31514.00Integrating Cardiac Magnetic Resonance into Athlete Screening: Early Findings in Professional Football PlayersZ. Azeddoug
4JESFC27-73513.00Interest of biplane echocardiography to refine right atrial remodeling in atrial fibrillationL. Soulat Dufour
5JESFC27-34414.33Left atrial volumetric/mechanical coupling and outcomes after stroke or transient ischemic attackA. Fayssoil
6JESFC27-84313.67Right Ventricular Strain and Early Acute Heart Failure in Inferior STEMIE. Allouche
7JESFC27-32213.33Segmental myocardial strain for culprit artery identification in NSTEMI patients with preserved ejection fractionG. Ben Hassen
8JESFC27-83513.67Severe obstructive sleep apnea–hypopnea syndrome: associated cardiovascular echocardiographic parametersM. Abbassi
9JESFC27-50814.00Systemic venous congestion assessed by the VExUS score as a predictor of clinical outcomes in acute heart failure: A prospective studyF. Ben Ghorbel
10JESFC27-75313.67The correlation of epicardial adipose tissue thickness and peripheral artery disease severityA. Ben salem

04 - Valvulopathies

69soumis
52note ≥ 13
16en comm. orale
36en HUB
52total programmé

Communications orales

CO Mercredi — Session 1 (8/8 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-29116.33A Multimodal strategy to screen for and Rule-Out Delayed High-Grade Conduction Disturbances after TAVRM. Dugnach
2JESFC27-04716.67A selective gut–host metabolic shift in calcific aortic stenosis: kynurenine pathway activation and microbial cholesterol loss (GUT-CAS)C. Chong-Nguyen
3JESFC27-25415.67Contemporary management and outcomes of mitral stenosis in French overseas territories: design of the multicenter RHUMDROM registryT. Si Moussi
4JESFC27-71316.00Does longer female life expectancy explain superior survival after TAVI?M. Boute
5JESFC27-01415.33Drug-Use-Associated Infective Endocarditis: Recurrence, Surgical Management, and One-Year OutcomesM. Philip
6JESFC27-47817.00Durability of Percutaneous Mitral Commissurotomy in Rheumatic Mitral Stenosis: A 30-Year Real-World Cohort StudyR. Harbaoui
7JESFC27-52715.33Efficacy and safety of apixaban in the first three months following surgical bioprosthetic valve replacement or valve repair in patients with atrial fibrillationP. Lust
8JESFC27-75417.67Evolution and prognostic impact of residual tricuspid regurgitation after transcatheter mitral valve replacement (TMVR)N. Groshenry
CO Jeudi — Session 1 (8/8 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-22516.33First-In-Human evaluation of a dual-flow femoral arterial cannula for peripheral CPB in minimally invasive cardiac surgeryP. Demondion
2JESFC27-86716.67Foetal prognosis, neonatal morbi-mortality and children long-term follow-up after mitral balloon commissurotomy in pregnant womenS. Boudiche
3JESFC27-18018.33Guideline-based undertreatment in multiple and mixed valvular heart disease: insights from the EACVI-MMVD international registryA. Boubeker
4JESFC27-04817.33Late-Systolic Primary Mitral Regurgitation: Phenotype and Severity Assessment by Echocardiography and CMRA. Altes
5JESFC27-74816.67Non-invasive ultrasound therapy using Valvosoft: sub-analysis of retreatmentsE. Messas
6JESFC27-59716.67Predictors of Early Death After Transcatheter Edge-to-Edge Mitral Valve Repair: Results From the MAVERICK registryA. Souquet
7JESFC27-47718.33Pulmonary arterial systolic pressure evolution after transcatheter edge-to-edge mitral valve repair and its association with outcomesG. Suc
8JESFC27-78217.33When echoes disagree : prognostic implications of abnormal postoperative TOE in patients with normal TTE after infective endocarditis surgeryI. Idyahia

Sessions HUB

HUB Mercredi — Session 1 (12/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-36314.67A rare mixed valvular disease in young patients with mucopolysaccharidosisN. Ali Tatar
2JESFC27-26913.33Advanced Mitral and Aortic Regurgitation: Characterization of Distinct Mechano-Energetic Profiles by Myocardial Work in a Monocentric StudyS. Bachtarzi
3JESFC27-33214.67Aortic Valve Calcium Score in Severe Aortic Stenosis with Cardiac Amyloidosis: Insights from a Prospective Cohort StudyM. Daller
4JESFC27-13514.67Automated curvature-based CT tortuosity for transfemoral TAVI planningT. Lohse
5JESFC27-77815.00Baseline atrial fibrillation identifies a higher-risk phenotype after percutaneous mitral commissurotomy in rheumatic mitral stenosisH. Amamou
6JESFC27-01514.00Clinical Implications of Cardiac Damage Staging Discrepancies in Patients with Severe Aortic Stenosis Undergoing TAVIQ. Battistolo
7JESFC27-18313.00Clinical phenotypes and prognostic trajectories in combined mitral and tricuspid regurgitation: a large-scale machine-learning analysisL. Gegout
8JESFC27-38614.33Comparison of Early Hemodynamic Profiles After TAVI Versus Surgical Aortic Valve Replacement Using Impedance CardiographyL. Kthiri
9JESFC27-38713.67Correlation Between Impedance Cardiography and Echocardiography in Severe Aortic Stenosis: Analysis Before and After Aortic Valve ReplacementL. Kthiri
10JESFC27-57813.33Description and short- and long-term outcomes of patients undergoing urgent trancatheter aortic valve implantationE. Hritcu
11JESFC27-42213.33Determinants of Restenosis After Percutaneous Mitral Commissurotomy: Integrating Anatomical and Hemodynamic PredictorsR. Harbaoui
12JESFC27-18915.00Epidemiology, management and in-hospital outcomes of patients with mixed and multiple valvular heart disease: the international EACVI-MMVD StudyT. Pezel
HUB Jeudi — Session 1 (12/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-82614.00Favorable Outcomes Despite Small Neo-Left Ventricular Outflow Tract Area in Valve-in-Valve Transcatheter Mitral Valve ReplacementI. Magana
2JESFC27-41813.33From Procedural Success to Disease Modification: Rethinking Endpoints in Percutaneous Mitral CommissurotomyR. Harbaoui
3JESFC27-22313.00Hybrid transatrial valve in mitral annular calcification: planning and midterm outcomesC. de la bourdonnaye
4JESFC27-07314.67Long-term Durability of Mitral Valve Repair: A 15-Year Comparison of Resection and Neo-chordae TechniquesR. Volpe
5JESFC27-68513.00Mean mitral gradient in rheumatic mitral stenosis: Hemodynamic and echocardiographic correlates in a contemporary cohortA. Haddad
6JESFC27-35513.67Mitral valve prolapse without regurgitation impairs overall left ventricular myocardial functionT. Le Tourneau
7JESFC27-12013.67Moderate Aortic Regurgitation in Severe Mitral Valve Disease: Phenotype, Management, and Early Outcomes from the EACVI-MMVD RegistryL. Perrard
8JESFC27-44313.33Mycotic Cerebral Aneurysms in the Setting of Infective Endocarditis: Insights from Six CasesE. Ben Brahim
9JESFC27-77514.67Non-invasive ultrasound therapy using Valvosoft: A new way to treat moderate aortic stenosis patients?E. Messas
10JESFC27-77713.00Predictive Factors of Neurological Complications in Infective Endocarditis: A Single-Center Retrospective Cohort StudyI. Kammoun
11JESFC27-30214.33Prognostic factors associated with in-hospital mortality in infective endocarditis: a retrospective study of 110 patientsI. Abbassi
12JESFC27-07414.33Prognostic value of the B-type natriuretic peptide ratio in patients with chronic aortic regurgitationS. El Banani
HUB Vendredi — Session 1 (12/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-59915.00Recurrent Mitral Regurgitation After Successful Transcatheter Edge-to-Edge Repair: Incidence, Predictors, and Long-Term Outcomes in a Real-World CohortV. Quentin
2JESFC27-38415.00Reduced butyrate after TAVI is associated with increased inflammatory activation: insights from a multi-omics cohort (Swiss-GUT-TAVI)C. Chong-Nguyen
3JESFC27-66813.67Rheumatic lesions of the pulmonary valve: a systematic review of the literatureW. M. Nacanabo
4JESFC27-78313.33Rheumatic valvular disease in Africa: a review of current evidence and North African perspectivesM. Lazraq
5JESFC27-86113.33Severe rheumatic mitral stenosis at the National Cardiology Center of Nouakchott: an echocardiographic study of a cohort of 301 patientsV. Isselmou
6JESFC27-24013.33Sex-specific modulation of gut-derived metabolites in calcific aortic stenosisS. Atighetchi
7JESFC27-17315.00Sex-Specific Prognostic Implications of Cardiac Remodeling Parameters in Primary Mitral RegurgitationV. Pecriaux
8JESFC27-81015.33Subclinical Left Ventricular Dysfunction in Isolated Mitral Stenosis Assessed by 2D Speckle Tracking EchocardiographyE. Ben Brahim
9JESFC27-36014.00Systematic imaging REASSESSment of embolic complications before antibiotic discontinuation in Infective Endocarditis : REASSESS-IE Study V. MAURY
10JESFC27-68814.33TAVI After Valve-Sparing Aortic Root Replacement: Anatomical Challenges and Procedural StrategiesA. Hayek
11JESFC27-03815.33Telemedicine Enhances Anticoagulation Control and Clinical Outcomes in Mechanical Valve PatientsK. Louay
12JESFC27-17714.00Use and Impact of Multimodality Imaging Beyond Transthoracic Echocardiography in Multiple and Mixed Valvular Heart Disease: Insights from the EACVI-MMVD RegistryS. Toupin

05 - Rythmologie et stimulation cardiaque

57soumis
35note ≥ 13
16en comm. orale
21en HUB
37total programmé
ℹ 2 abstract(s) sous le seuil de 13 ont été repêché(s) pour compléter une session complète.

Communications orales

CO Jeudi — Session 1 (8/8 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-51516.00Alcohol-Based Chlorhexidine Versus Povidone-Iodine for Prevention of Cardiac Implantable Electronic Device Infections: Combined Evidence From CHLOVIS, WRAP-IT, and PADITA. Da Costa
2JESFC27-05414.67Between his and kent let Ajmaline light the wayR. Bourghoud
3JESFC27-57015.50Coronary Safety of Combined Pulsed Field Ablation and Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation Without Preventive Nitrate AdministrationA. Da Costa
4JESFC27-78815.00Deep sedation and In-Hospital Mortality in Electrical Storm: A Propensity Score-Matched Analysis from the FrenchStorm Prospective RegistryP. Groussin
5JESFC27-39215.50Determinants of hemodynamic intolerance of ventricular tachycardia in implantable cardioverter-defibrillator recipients: implications for individualized device programmingP. Divet
6JESFC27-56715.50Early Mechanistic Effects of Left Bundle Branch Area Pacing on Ventricular Synchrony and RemodelingT. Barre
7JESFC27-81416.00Electrical Storm in Contemporary Practice: Management, Inter-Center Heterogeneity, and Mortality : The FrenchStorm Nationwide Prospective CohortP. Groussin
8JESFC27-60515.00Epicardial box lesion with the Gemini-S™ clamp during concomitant cardiac surgery: feasibility and rhythm outcomes in persistent atrial fibrillation — a single-center pilot studyK. Azarnoush
CO Vendredi — Session 1 (8/8 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-35116.50HCN4 genetic architecture and genotype-phenotype correlation in a large french cohortA. Bloch
2JESFC27-22016.33In-hospital complications after left atrial appendage occlusion and their impact on long-term mortality: a multicenter studyT. Pommier
3JESFC27-82217.50Independent pathogenicity of a DPP6 promoter variant in familial idiopathic ventricular fibrillation: evidence from co-segregation analysisP. Groussin
4JESFC27-05916.33Nationwide trends in paediatric pacemaker implantation in France, 2014–2024V. Olié
5JESFC27-61515.50Pre-procedural venography for lead-related venous obstruction in cied reinterventions: diagnostic yield and PVO-Risk score developmentJ. Nguadi
6JESFC27-59415.50Predicting left ventricular ejection fraction change at follow-up with ecg-only criteria at conduction system pacing implantM. Fosse
7JESFC27-07515.00Temporal trends in permanent pacemaker implantations in France (2018-2024)L. Semenzato
8JESFC27-36416.00Thoracoscopic and hybrid atrial fibrillation ablation for stand-alone atrial fibrillation: ten years single center experienceC. D'Alessandro

Sessions HUB

HUB Jeudi — Session 1 (11/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-63613.00Anticoagulation in Atrial Fibrillation in Morocco: The Persistent Impact of Rheumatic Valvular Disease on the Choice Between VKAs and DOACsZ. Moulay Rchid
2JESFC27-51614.33Does Vein of Marshall Ethanol Infusion Prevent Acute Mitral Isthmus Reconnection? Insights From AFFERA-Based Persistent AF AblationA. Da Costa
3JESFC27-74513.50Early conduction system pacing (CSP) in patients with presumed left bundle branch block–induced cardiomyopathyR. Venencia
4JESFC27-70613.50Early CRT response: substrate and post-implant QRS as key correlates in a real-world african tertiary centre cohortN. Dahimene
5JESFC27-70813.50Early experience with conduction system pacing in an emerging electrophysiology program: feasibility, validation strategy and durability of physiological captureN. Dahimene
6JESFC27-54714.50GPSS-AF Study: General Practitioner Senior Screening for Atrial Fibrillation in Primary Care — A Community-Based Screening Program in the Ariana Region, TunisiaA. Ben Halima
7JESFC27-43414.00Impact of Cell Saver on Postoperative Atrial Fibrillation in Myocardial Revascularization SurgeryK. Salmen
8JESFC27-19512.67 repêché <13Impact of Continuous Positive Airway Pressure on Left Atrial Remodeling and Atrial Fibrillation Recurrence after voltage-guided ablation in Patients with Severe Obstructive Sleep ApneaH. Marzak
9JESFC27-19713.67Impact of the CHA₂DS₂-VA Score on the Occurrence of Atrial Fibrillation and Major Adverse Cardiovascular Events after ST-Segment Elevation Myocardial InfarctionH. Marzak
10JESFC27-67414.00Indications and results of 24-hour holter ECG monitoring in patients being treated for obstructive sleep apnea syndrome: a report on 23 casesM. A. Sene
11JESFC27-09613.00Intracardiac conduction disorders in patients with renal function impairment hospitalized at CNHU-HKM in Cotonou, 2024-2025: frequency and associated factorsA. F. Soummonni
HUB Vendredi — Session 1 (10/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-67314.50Left bundle branch area pacing following transcatheter valve implantation: a single center experienceC. Granier
2JESFC27-79113.33Left Bundle Branch Area Pacing for Cardiac Resynchronization in Congenital versus Non-Congenital Heart Failure: A Prospective Comparative AnalysisM. Ben Halima
3JESFC27-71213.50Long-term left ventricular reverse remodeling with crt-p in heart failure with reduced ejection fraction and normal coronary arteriesJ. Fagouri
4JESFC27-07814.67Low-dose colchicine for prevention of post-operative atrial fibrillation after bypass surgery: results from the COLPOAF studyV. Roger
5JESFC27-13414.67Proof-of-concept for Holter-based automated identification of normal sinus rhythm in the general population and atrial fibrillation in the post-stroke populationL. Fiorina
6JESFC27-73014.33Pulsed-Field Ablation With Mapping: Optimization of Initial Pulmonary Vein Isolation SuccessM.-A. Nicola
7JESFC27-38512.67 repêché <13Residual Stroke Risk in Anticoagulated Atrial Fibrillation: Clinical Predictors of High-Risk PatientsS. Anwar
8JESFC27-21314.67Short-term prediction of atrial fibrillation onset using heart rate variability and ECG-based artificial intelligence in a real-world ambulatory populationJ.-M. Grégoire
9JESFC27-35614.00Trends and outcomes of major complications after Left Atrial Appendage Closure: A nationwide 10-year studyS. Beurtheret
10JESFC27-03914.00Two decades of first-time ICD implantation: temporal trends in patient characteristics and early outcomesA. Ait Khouya

06 - HTA/Vasculaire/ Métabolisme

34soumis
17note ≥ 13
8en comm. orale
9en HUB
17total programmé

Communications orales

CO Vendredi — Session 1 (8/8 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-66016.33Characteristics of the Resilient Phenotype in Patients with Familial Hypercholesterolemia: Results from the SAFIR StudyB. Cariou
2JESFC27-46016.00Medical Management vs Revascularization for Asymptomatic Carotid Stenosis: Contemporary Bayesian Network Meta-Analysis of RCTsR. Chopard
3JESFC27-17416.50National Analysis of Pulmonary Embolism Care Pathways and Organizational Heterogeneity in France: An SNDS StudyI. Benzidia
4JESFC27-17016.00Passive hypertension pre-screening from routine smart-scale weigh-ins: an arterial-stiffness-driven notification featureP. Binon
5JESFC27-01716.50Prevalence and one-year incidence of patient-healthcare professional discussions about sexual health in hypertensive adults in France: a cohort studyJ. Vay Demouy
6JESFC27-17616.00Real-world body composition and blood pressure changes following GLP-1 Receptor Agonist initiation: a causal inference study of connected device dataA. Chabassier
7JESFC27-72917.00Subtle cardiac abnormalities detected using four cardiac chambers strain echocardiography in malignant hypertensionL. Soulat Dufour
8JESFC27-49616.67Thoracic Aortic Aneurism associated with Bicuspid Aortic Valve: Limited Contribution of Genetic TestingO. Milleron

Sessions HUB

HUB Jeudi — Session 1 (9/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-80413.67Effect of Angiopoietin-Like Protein 3 Inhibition on HDL Function in Homozygous Familial HypercholesterolemiaA. Gallo
2JESFC27-31814.50Hypertension in Black Adults with Abdominal Obesity in Urban and Rural Areas of the Democratic Republic of the Congo (DRC): A Cross-Sectional StudyT. Tshiswaka Mutombo
3JESFC27-22213.33Independent determinants of Coronary Artery Calcium (CAC) score in routine practice using Log-Transformed ModelingN. Benyounes Iglesias
4JESFC27-77113.00Left Atrium Function Predictive Marker of Coronary Artery Disease in Hypertensive Type 2 Diabetic SubjectsN. Taleb Bendiab
5JESFC27-04014.00Lifestyle Intervention Restores Autonomic Balance in Patients With Elevated Blood Pressure: A Prospective StudyK. Louay
6JESFC27-61714.67Nocturnal hypertension and circadian blood pressure profiling with somnoTouch™ nibp: strengths and limitations compared with abpmZ. Henchiri
7JESFC27-32614.00Prevalence of elevated pulse pressure and associated factors in the province of Kasaï Oriental, Democratic Republic of the Congo (DRC): A cross-sectional studyT. Tshiswaka Mutombo
8JESFC27-27613.67Short-Term Renal Function Monitoring by Physicians After Initiation of Antihypertensive Therapy: A Cross-Sectional KAP Survey in Sub-Saharan AfricaC. Ngongang Ouankou
9JESFC27-74713.67Study of the evolution of 10-year overall cardiovascular risk among adults aged 40 to 60 over a 5-year periodA. R. Poda

07 - Recherche fondamentale & translationnelle

16soumis
13note ≥ 13
0en comm. orale
16en HUB
16total programmé
ℹ 3 abstract(s) sous le seuil de 13 ont été repêché(s) pour compléter une session complète.

Communications orales

Aucune session.

Sessions HUB

HUB Jeudi — Session 1 (8/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-74012.00 repêché <13Acute impact of hemodialysis on left ventricular function assessed by speckle tracking echocardiography in pediatric end-stage renal diseaseF. El Ayech Boudiche
2JESFC27-68916.00Angiopoietin-like 4 as an inflammatory-lipid amplifier driving residual post-ACS risk - insights from SPUM-acute coronary syndrome studyK. Miteva
3JESFC27-75513.33Can we predict cardiovascular risk in patients with familial hypercholesterolemia using polygenic predispositions?A. Rimbert
4JESFC27-20516.00Comparative Analysis of Immune Activation Following Heart and Kidney Transplantation in Non-Human PrimatesB. Poitier
5JESFC27-67715.33Female Balb/c pressure-overload model is associated with low transcriptional cardiac expression of ctla-4, a distinct class-switch humoral response and cardiac fibrosisV. San Martin Tardif
6JESFC27-09114.33Gender-specific Determinants of Non-adherence to Antihypertensive Treatment: a Cross-sectional Study across eight European CountriesA. Fourati
7JESFC27-48512.33 repêché <13Global Landscape of Cardiovascular Research: A Continental Bibliometric Analysis Standardized by Population and Physician DensityM. Temgoua Ngou
8JESFC27-33314.00Heart Rate Variability as an early marker of impending syncope during orthostatic stressV. Faivre-Rampant
HUB Vendredi — Session 1 (8/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-05112.67 repêché <13Hemodynamic strategies in pediatric critical care unit: Ultrasound-Guided transition within the ROSE FrameworkPD.-D. Batouche
2JESFC27-57314.33Impact of HLA evolutionary divergence on development of de novo donor-specific antibodies after heart transplantationR. Dorent
3JESFC27-39913.67Kinetic study of Endothelin 1: Dynamics and clinical relevance in myocardial infarctionE. C. Aboulaz
4JESFC27-20916.67Multifactorial Cardioprotective Effects of Grape Seed Flour in Post-ACS : A Randomized Controlled TrialH. Ben Slima
5JESFC27-03017.67Myocardial regeneration by macrophage-mediated epimorphosis in pig heart with right ventricular failure: toward an innovative therapy for cardiac failure?V. Lambert
6JESFC27-19314.67Performance of a Two-Dose Furosemide Stress Test under vasopressor support in pediatric Acute Kidney Injury: Preliminary results of a prospective monocentric studyD.-D. Batouche
7JESFC27-04916.00SGLT2 inhibitors have the potential to reduce pulmonary arterial hypertensionF. Antigny
8JESFC27-47516.67Triple GLP-1R/GIP-R/GCGR activation synergistically suppresses macrophage-driven oxidative stress and activation in human epicardial adipose tissue from patients with a history of atrial fibrillationW. Fakih

08 - Epidémiologie & prévention, Réadaptation & sport, Sommeil

56soumis
50note ≥ 13
16en comm. orale
34en HUB
50total programmé

Communications orales

CO Jeudi — Session 1 (8/8 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-24317.00Cardiac Telerehabilitation for coronary patients: National Evaluation of the WALKHOP ProgramM. Six
2JESFC27-69318.00Coordinated Multidisciplinary Care Improves Cardiovascular Risk Factor Control After Coronary or Peripheral Revascularization: One-Year Results From a French Article 51 Experimental ProgramP. Léger
3JESFC27-16516.67Determinants of Exercise Capacity Improvement in Cardiac Rehabilitation: A Multi-Center Registry Analysis of 3,802 Patients in the French "Structures Libérales Légères" ModelF. Zorès
4JESFC27-26316.33Dose–Response Relationship Between Exercise-Based Cardiac Rehabilitation and Long-Term Survival Indices in LVAD RecipientsP.-M. Leprêtre
5JESFC27-55816.33Genetic contribution to non-syndromic aortic dissection: the experience of the French reference centerO. Milleron
6JESFC27-61617.00Global awareness of sudden cardiac arrest: insights from worldwide cross-sectional surveyA. Bonny
7JESFC27-49716.33Impact of the 2024 European guidelines on hypertension classification and therapeutics in the CARVAR 92 cohortF. Wullems
8JESFC27-02017.67Mixing 1:1 HIIT and MICT in early to very early phase HTx recipients : a retrospective study from a 506 patients/12 years prospectively-collected databaseL. Poirette
CO Vendredi — Session 1 (8/8 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-17817.67Predictive value of EuroSCORE II in contemporary cardiac surgery : insights from a multicentric national registryJ. Piccoli
2JESFC27-12116.33Predictors of cardiac rehabilitation completion after acute myocardial infarction in young women: an ancillary study of the WAMIF registryP.-G. Piriou
3JESFC27-38816.33Premature atrial contractions: A powerful marker of occult atrial fibrillation in acute ischemic strokeO. Haddar
4JESFC27-72016.00Real-world adherence to the new guidelines for cardiovascular prevention in people living with type 2 diabetes (PwT2D)J.-F. Thebaut
5JESFC27-27017.00Sedentarity and premature Cardiovascular-risk concerns in medical resident: a multicenter cross-sectional studyR. Kallel
6JESFC27-34016.33Systemic inflammation across heart failure phenotypes: comorbidities, background therapies and inflammatory burden in the French cohort of the international POSEIDON studyN. Girerd
7JESFC27-53216.67The CHAMELEON National Campaign: A Multidisciplinary Strategy for Early Detection of Transthyretin Cardiac AmyloidosisT. Damy
8JESFC27-60616.33Zoster Vaccination and Long-term Cardiovascular and Dementia Risk in Older Adults: A Propensity Score–Matched Cohort StudyA. Hacil

Sessions HUB

HUB Jeudi — Session 1 (11/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-36113.33Access to cardiac surgery in Africa: how can you imagine the future ?R. Sayah
2JESFC27-18214.67Adult vaccination in heart failure: a national multicentre cross-sectional study within a telemonitoring programmeO. Hanon
3JESFC27-86313.33Anthropometric data: a screening tool for severe obstructive sleep apnea in Tunisian population with atrial fibrillation?M. Ben Halima
4JESFC27-54014.00Applicability of the 2017 international recommendations for electrocardiographic interpretation in athletes among black individuals: the example of senegalese professional football leagueM. Ndiaye
5JESFC27-24513.33Association of Advanced Coronary Artery Calcification Assessed by Coronary Artery Calcium Scoring with Lipoprotein (a) and carotid atherosclerosis in Asymptomatic PatientsA. Matta
6JESFC27-15915.00Cardiac home- rehabilitation specificities in women, can we bridge the gender-gap?R. Kallel
7JESFC27-31613.33Cardiovascular comorbidities in obstructive sleep apnea: associations with Disease severity in a Tunisian cohortR. Kallel
8JESFC27-76714.67Cardiovascular multimorbidity burden predicts stroke severity and six-month functional outcome in ischemic strokeH. Amamou
9JESFC27-13615.33Cardiovascular Outcomes Associated with Human Metapneumovirus Infection in Adults: A Systematic Literature ReviewP. Loubet
10JESFC27-13313.33Effects of training and competition on the echocardiographic parameters in black athletes: example of a Senegalese professional league teamC. M. B. M. Diop
11JESFC27-47613.00Electrocardiographic findings in athletes: a study of 100 football playersZ. Azeddoug
HUB Jeudi — Session 2 (11/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-54914.00Employment status and socioeconomic deprivation among adults with Marfan syndrome is related to aortic dissection but not with preventive aortic surgeryO. Milleron
2JESFC27-34114.67Epidemiology, temporal trends, and prognostic disparities after myocardial infarction in France: a population-based analysis using the comprehensive French national SNDS databaseN. El Bèze
3JESFC27-36815.00Expected population benefit of optimised hypertension treatment strategies in France: a modelling studyC. Grave
4JESFC27-18613.67Geographical disparities in vaccination uptake among 1,100 telemonitored heart failure patients across metropolitan and overseas FranceN. Girerd
5JESFC27-80214.00Heart rate variability as a marker of cardiovascular risk in taxi drivers: a cross-sectional studyE. Allouche
6JESFC27-35815.67High-risk profile in infective endocarditis: clinical and echocardiographic predictors in a retrospective cohortI. Abbassi
7JESFC27-34714.33Impact of HELLP syndrome on women’s Middle and Long-Term Cardiovascular RiskG. Lailler
8JESFC27-36515.67Know your numbers: where does France stand?C. Grave
9JESFC27-67914.00Left Atrial Enlargement as a Marker of Physiological Electrical Remodeling in Amateur Football Players: A Cross-Sectional StudyO. Taibi
10JESFC27-32015.33Left ventricular hypertrophy in obstructive sleep apnea-hypopnea syndrome: a comparative studyR. Kallel
11JESFC27-67813.00Risk factor burden and management of acute coronary syndromes in a lebanese tertiary hospitalT. Abdel Massih
HUB Vendredi — Session 1 (12/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-74614.33Secondary prevention after acute coronary syndrome treated with percutaneous coronary intervention: impact of cardiovascular risk factor control in a north african studyW. Satouri
2JESFC27-73215.00Secondary prevention After Myocardial Infarction: Are Therapeutic Targets Achieved at 1 Year?F. El Ayech Boudiche
3JESFC27-06114.33Sevenfold Inter-Center Variation in Female Representation and Its Association With Myocardial Severity in ATTR-CM: Data From the Nationwide HEAR RegistryA. Zaroui
4JESFC27-18413.33Sex-related disparities in vaccination uptake and pathways in 1,100 telemonitored heart failure patientsR. Esser
5JESFC27-12915.67Sex-Specific Trajectories of Arterial Stiffness: A Large-Scale Description of 38 Million Real-World Pulse Wave Velocity MeasurementsB. Vittrant
6JESFC27-24914.00Signal-Morphology Impedance-derived cardiac output kinetics during cardiopulmonary exercise testing as an indirect marker of aortic valve opening in patients with a left ventricular assist deviceJ.-Y. Hoang
7JESFC27-27213.67Study of cardiovascular risk in the medical population: Results of the Doctors Care studyB. Trabelsi
8JESFC27-39713.33The changing face of atrial fibrillation in elderly hospitalized patients in Morocco: burden, frailty and cardio-geriatric insightsM. Lazraq
9JESFC27-46914.33The reality of CV inflammation in patients with ASCVD: French cohort of the international POSEIDON studyF. Ivanes
10JESFC27-06815.33Trends in acute coronary events between 2012 and 2023: data from French registries of ischemic heart diseaseT. Léguillette
11JESFC27-32814.00Unexplained Syncope: Does Dysautonomia Phenotyping Improve Diagnosis and Management?Z. Azeddoug
12JESFC27-53914.33Unscheduled cardiology consultations: Uberization of healthcare delivery or a new sanitary imperative?D. Bodez

09 - Cardiopédiatrie et cardiopathies congénitales

43soumis
32note ≥ 13
8en comm. orale
24en HUB
32total programmé

Communications orales

CO Jeudi — Session 1 (8/8 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-78116.00Data@KidsHeart : a digital tool for visualizing neurodevelopmental follow-up data in children with CHDB. O. Meissa
2JESFC27-56617.50GACH Study – Tolerability and Efficacy of SGLT2 Inhibitors in Adults with Congenital Heart Disease and Heart FailureO. Domanski
3JESFC27-28216.67Long-term follow-up of adults with fontan circulation: predictors of death or transplantationC. Oger
4JESFC27-63116.67Long-term survival after late complete repair of tetralogy of Fallot in children from developing countriesN. Gignoux
5JESFC27-63516.33Modeling Stage-One Hypoplastic Left Heart Syndrome Strategies Using a Closed-Loop Lumped Parameter FrameworkA. M. Pradhan
6JESFC27-87917.00Navigating in heart specimens: building a digital micro-CT and virtual reality platform for congenital heart disease educationC. Huet
7JESFC27-02816.00Off-Label Use of the Amplatzer Duct Occluder II for Small-to-Moderate Perimembranous VSD Closure: Insights from the PERICLOSE RegistryR. Haddad
8JESFC27-77618.00Transcatheter correction versus surgery for sinus venosus defect: a prospective multicenter French studyG. Albenque

Sessions HUB

HUB Jeudi — Session 1 (12/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-87014.00Associated factors to recoarctation in a large cohort of infant operated of aortic coarctation before 1 year of ageO. Werner
2JESFC27-51714.00Beyond palliation: pregnancy and motherhood after Fontan surgeryD. Jacquemart
3JESFC27-82814.67Beyond Successful Closure: Predictors of Atrial Fibrillation and Residual Shunt After PFO ClosureM. Alaoui Yazidi
4JESFC27-78013.00Echocardiographic assessment of right ventricular dysfunction and pulmonary regurgitation after repaired tetralogy of fallot: comparison with cardiac MRIH. Amamou
5JESFC27-02713.50Effects Of Under- And Over-Expansion On Myval OCTACOR Transcatheter Heart Valve Function: Bench Simulation StudyR. Haddad
6JESFC27-26713.00Efficacy and Safety of PFO closure: Insights From a Cohort of 160 PatientsM. Alaoui Yazidi
7JESFC27-85714.67Etiological Profile of Pediatric Heart Failure: A Retrospective Study in a Tertiary Care CenterY. Messaoudi
8JESFC27-23215.50Integrated Echocardiographic Right Ventricular Myocardial Work and Cardiopulmonary Exercise Testing in Pediatric Precapillary Pulmonary Arterial Hypertension: A Pilot StudyR. Ghenghea
9JESFC27-78915.00Long-term outcomes of percutaneous transcatheter pulmonary valve implantationS. Quennelle
10JESFC27-23914.50Mavacamten Therapy in Adolescent Obstructive Hypertrophic Cardiomyopathy: Real-World Safety and EfficacyR. Ghenghea
11JESFC27-53714.50Predictors of atrial arrhythmia after percutaneous closure of ostium secundum atrial septal defectG. Albenque
12JESFC27-75714.33Prevalence and Circadian Patterns of Ambulatory Hypertension in Children and Young Adults After Aortic Coarctation RepairF. Yahia
HUB Vendredi — Session 1 (12/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-54215.33Prognosis of pediatric restrictive cardiomyopathy: more severe in sarcomeric variantsC. Gardin
2JESFC27-85614.00Prognostic factors of adverse obstetric outcome after Fontan surgeryJ. Meyroneinc
3JESFC27-23714.00Pulmonary Valve–Sparing Repair of Tetralogy of Fallot with T-Shaped Infundibulotomy: Five-Year Follow-Up ResultsR. Ghenghea
4JESFC27-86514.67Pulse oximetry a game changer in early detection of critical cyanotic congenital heart diseases insights from a study of 972 newbornsF. E. El Ktaibi
5JESFC27-41613.33Quality of Life in Patients with Repaired Tetralogy of Fallot: Association with Exercise CapacityN. Amdouni Moussi
6JESFC27-76313.00The RISE-UNI-ASD study: Retrospective Registry for the International Safety and Efficacy results of the UNI Occluders for closure of multiple Atrial Septal DefectsN. Pioch
7JESFC27-49915.00Thirty Years of Innovation in Transcatheter Fontan Completion: A Systematic Literature ReviewA. Benfreha
8JESFC27-25616.00Thromboembolic and Bleeding Events in Patients With Fontan Circulation: A Long-Term Follow-Up StudyM. Albertini
9JESFC27-40415.00Transcatheter Aortic Valve Implantation in Adults with Complex and Geriatric Congenital Heart DiseaseM. Albertini
10JESFC27-02615.00Transcatheter Fontan Completion: A Systematic Literature ReviewR. Haddad
11JESFC27-04313.33Value of Functional Echocardiography in the Preterm Infant: Diagnostic and Hemodynamic ImplicationsK. Louay
12JESFC27-79413.50Very large devices for transcatheter closure of ostium secundum atrial septal defect: higher procedural risk but comparable long-term outcomesG. Albenque

10 - Cardiologie générale / Ethique

17soumis
7note ≥ 13
0en comm. orale
0en HUB
0total programmé

Communications orales

Aucune session.

Sessions HUB

Aucune session.

11 - Paramédical

4soumis
4note ≥ 13
0en comm. orale
4en HUB
4total programmé

Communications orales

Aucune session.

Sessions HUB

HUB Vendredi — Session 1 (4/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-52015.33Better Breathing in Cardiac Rehabilitation: A Proposal for Respiratory EducationE. Pruliere
2JESFC27-54114.00Consultation without an appointment: an unscheduled but organized care managementA. Boussemart
3JESFC27-61113.67Standardized procedural packs to support multidisciplinary workflow, training and patient information in cardiologyM.-L. Jean-Jacques
4JESFC27-10514.50Technology outpaces cath lab teams: National evidence of a readiness gap, role redistribution, and governance needs among nurses and radiographersC. Mette

12 - Urgences et soins cardiaques intensifs

20soumis
10note ≥ 13
0en comm. orale
10en HUB
10total programmé

Communications orales

Aucune session.

Sessions HUB

HUB Jeudi — Session 1 (10/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-45816.00An AI-driven Model to Improve Prediction of Early Mortality in Acute Pulmonary Embolism: The VITAL-PE ScoreR. Chopard
2JESFC27-87614.00Diagnostic yield and pronostic impact of CICU admission versus emergency department redirection in suspected NSTE-ACSE. Roubez
3JESFC27-48714.67From acute-phase inflammatory response to residual inflammatory risk after myocardial infarction: trajectories of C-reactive protein from admission to 1 yearC. Dolci
4JESFC27-30513.00Integrating hypochloremia and venous congestion to predict acute kidney injury in acute heart failureF. Ben Ghorbel
5JESFC27-30814.00Low urinary sodium predicts short-term mortality in acute heart failure: Insights from a prospective studyF. Ben Ghorbel
6JESFC27-33716.00Residential Temperature, Greenness, and Long-Term Mortality After Cardiogenic Shock: Insights from the FRENSHOCK RegistryC. Delmas
7JESFC27-46513.00Risk stratification in acute pulmonary embolism using visual coronary artery calcium assessment on CTN. Nguyen
8JESFC27-16313.33Risk stratification using right bundle branch block in patients with acute pulmonary embolism (From PERMIR)L. Aziz
9JESFC27-50215.00Socio-economic deprivation and long-term mortality after cardiogenic shock: insights from the FRENSHOCK nationwide registryA. Trimaille
10JESFC27-72514.33The R modifier of the AHA/ACC 2026 classification in acute pulmonary embolism: clinical phenotype, complementary value to sPESI, and prognostic signal (first Maghrebi cohort)O. El Fadel

13 - Cardio-oncologie

18soumis
12note ≥ 13
0en comm. orale
12en HUB
12total programmé

Communications orales

Aucune session.

Sessions HUB

HUB Vendredi — Session 1 (12/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-23615.50Association Between Acute Graft-Versus-Host Disease and Early Cardiotoxicity After Allogeneic Hematopoietic Stem Cell TransplantationJ. Hudelo
2JESFC27-29015.33Cardiac Magnetic Resonance–Derived Hemodynamic Forces Detect Subclinical Myocardial Dysfunction in Childhood and Early Young Adult Cancer SurvivorsT. Goncalves
3JESFC27-26515.00Cardiotoxicity in pembrolizumab-treated early-stage triple-negative breast cancer: a real-world studyL. Dib
4JESFC27-28914.00Early global atrial dysfunction following anthracycline-based chemotherapy: a prospective studyW. Hamdi
5JESFC27-85215.00Early global atrial dysfunction following anthracycline-based chemotherapy: a prospective studyW. Hamdi
6JESFC27-86213.67Impact of taxane type and cumulative dose on myocardial deformation in breast cancer patients: paclitaxel versus docetaxelW. Hamdi
7JESFC27-21015.00Phenotypic Clustering of Allogeneic Hematopoietic Stem Cell Transplant Recipients Associated with Cardiovascular EventsT. Goncalves
8JESFC27-12416.67Reciprocal impact of cancer and acute coronary syndrome on survival: A global real-world analysis using the TriNetX research networkL. Benoist
9JESFC27-85814.00Subclinical right ventricular cardiotoxicity in breast cancer: superiority of RV longitudinal strain over conventional parameters during sequential chemotherapyW. Hamdi
10JESFC27-33617.00Troponin to detect major cardiovascular adverse events on immune checkpoint inhibitors : a propensity matched multicentre retrospective studyI. Hamdi
11JESFC27-52615.33Two-year NT-proBNP trajectories after breast cancer radiotherapy and association with subclinical cardiac dysfunctionS. Jacob
12JESFC27-67514.00Value of left atrial strain for early detection of anthracycline-related cardiotoxicity in cancer patientsA. Turki

14 - Cardiologie tropicale

9soumis
4note ≥ 13
0en comm. orale
7en HUB
7total programmé
ℹ Cette session HUB combine les 4 abstracts propres au thème et 3 abstracts prêtés par « Cardiologie générale / Éthique » (mieux notés).

Communications orales

Aucune session.

Sessions HUB

HUB Jeudi — Session 1 (7/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-45413.33Cardiac abnormalities and associated factors in adolescents living with HIV: a clinical, electrocardiographic and echocardiographic approach at the Chantal Biya foundationC. Ngongang Ouankou
2JESFC27-69415.67Embolic Events after Left Atrial Appendage Closure for Recurrent Embolic Events Despite AnticoagulationM. Benamer
3JESFC27-53816.33Five ecoprescription rules in cardiology to decrease the greenhouse gas emissions of medical prescriptionsP. Bonnet
4JESFC27-10015.67Gynecological and Urinary Bleeding in Women with Atrial Fibrillation Receiving Oral Anticoagulants, an Analysis of DOACs vs. Warfarin in COMBINE-AFV. Monguillon
5JESFC27-62313.33Incidence and cardiovascular risk factors of Sudden Death in the Beninese Defense and Security Forces: A Retrospective Study from 2018 to 2021A. F. Soummonni
6JESFC27-10213.67Orthostatic blood pressure changes and factors associated with orthostatic hypotension and hypertension in adults with diabetes mellitus in Cameroon: A cross-sectional studyC. Nkoke
7JESFC27-21216.67Sub-saharan africa climate and blood pressure variability: an africa in miniature multicenter studyL. A. Tasong Mbosso

15 - Santé digitale

26soumis
18note ≥ 13
0en comm. orale
18en HUB
18total programmé

Communications orales

Aucune session.

Sessions HUB

HUB Jeudi — Session 1 (9/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-31413.67AIRFORCE-2 protocol: screening for valvular or structural heart disease using Surface Motion Camera (SMC), an exploratory study of feasibility and diagnostic performanceF. Lemaître
2JESFC27-65114.33Artificial intelligence shaping medical decisions in clinical cardiology practice. An International SurveyW. Amara
3JESFC27-29714.33Automated ESC SCORE2 Cardiovascular Risk Calculation Using a Hospital Health Data Warehouse: A Feasibility StudyA. Fourati
4JESFC27-79214.33Ballistocardiographic assessment of altered systolic ejection dynamics in aortic stenosisE. Abdessater
5JESFC27-30414.33Cardiac CT Improves Artificial Intelligence Prediction of Cardioembolic Etiology in Acute Ischemic StrokeC. Guenancia
6JESFC27-02913.33Comparative Accuracy of a Predictive Algorithm Versus Cardiologist Assessment for 90-Day Readmission in Decompensated Chronic Heart FailureG. Mercier
7JESFC27-62014.00Development and internal validation of an xgboost model for 5-year major cardiovascular event prediction: a multicentric retrospective study of 623 moroccan patientsJ. Nguadi
8JESFC27-52214.33Diagnostic performance of a mobile application for predicting left ventricular ejection fraction categories in a cardiology departmentM. Chagdali
9JESFC27-03113.00Evaluation of the Diagnostic Capabilities of Large Language Models for Electrocardiographic Image Analysis: A Comparative Study of 150 CasesW. M. Nacanabo
HUB Vendredi — Session 1 (9/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-14614.50Governance-related concern and regular use of large language models among cardiologists: an ancillary study of the INSIGHT-AI France surveyG. Bailly
2JESFC27-56414.67Myocardial infarct quantification using iterative driven strategies based on clinical metrics: a clinical researcher's approachP. Croisille
3JESFC27-01115.33One-year evolution of artificial intelligence adoption in cardiology: a longitudinal multiprofessional survey (INSIGHT-AI France)S. Domart
4JESFC27-26616.67PASTEC: an open clinical infrastructure for data aggregation and prospective validation of AI in cardiac remote monitoringB. Sacristan
5JESFC27-01016.50Patient acceptability, trust conditions and barriers to an AI virtual assistant in cardiology: the nationwide AIDOPT studyL.-M. Desroche
6JESFC27-65314.33Patterns, Perceptions, and Professional Use of Social Media Among Healthcare Professionals: A Mixed-Methods StudyW. Amara
7JESFC27-56516.00Powering precision cardiology: The INTELLIGENCIA initiative redefines and secures the use of contrast-enhanced cardiac MRI dataP. Croisille
8JESFC27-57213.67Rank order of candidates for heart transplantation in France: an explainable machine learning analysisR. Dorent
9JESFC27-15615.00Reducing cardiovascular risk with an innovative solution combining digital and professional healthcare interventionsG. Sit

16 - Enseignement, formation et simulation

5soumis
4note ≥ 13
0en comm. orale
0en HUB
0total programmé

Communications orales

Aucune session.

Sessions HUB

Aucune session.

Session HUB supplémentaire — hors grille officielle

⚠ Cette session combine le reliquat de « Cardiologie générale / Éthique » (4 abstracts, après prêt des 3 meilleurs à Cardiologie tropicale) et la totalité de « Enseignement, formation et simulation » (4 abstracts). Elle n'a pas de créneau prévu dans la grille du 260708 — jour/salle à définir par le comité.
HUB A programmer — Session 1 (8/12 sélectionnés)
Statut de la session :
#Réf.NoteTitreOrateurDéplacer
1JESFC27-34613.50Carbon footprint of the cardiology department of the Le Havre Hospital GroupP. Bonnet
2JESFC27-37514.33Emotional Impact of Patient Death Across Cardiology Subspecialties: A Cross-Sectional Study of 545 French Adult CardiologistsT. Damy
3JESFC27-37813.67Emotional profiles of French physicians facing ten patient death scenarios in clinical practice: a novel systematic mapping (HEART-DEATHS, n=497)T. Damy
4JESFC27-88513.50How to measure INTRA-cardiologist variability in prescription?A. Benani
5JESFC27-48614.67International survey on awareness, knowledge and genetic testing practices in inherited cardiac diseases among healthcare professionalsM. Temgoua Ngou
6JESFC27-03413.33Mobile-First Web and Captioned Video as mHealth Equity Enablers in French-language Cardiology Education: A Multi-Country Learning Analytics Case StudyT. Roussel
7JESFC27-19016.00Self-monitoring of oral anticoagulation INR with CoaguChek INRange® versus standard laboratory prothrombin time (PT/INR): IMM experience 2022-2026A. Dibie
8JESFC27-30914.00Simulation-based training improves the performance of residents in vascular access on complex phantoms – a pilot randomised studyS. Voicu

Abstracts non retenus par manque de place (18)

ThèmeRéf.NoteTitre
02 - Insuffisance cardiaque et cardiomyopathiesJESFC27-47013.67Clinical phenotyping and prognostic implications in patients with heart failure with preserved ejection fraction: a cluster-based analysis
02 - Insuffisance cardiaque et cardiomyopathiesJESFC27-34513.67Diastolic dysfunction and outcomes in myotonic dystrophy type 1
02 - Insuffisance cardiaque et cardiomyopathiesJESFC27-61813.67In-hospital initiation of SGLT2 Inhibitors in patients with acute heart failure: impact on all-cause in-hospital mortality, a retrospective cohort study
02 - Insuffisance cardiaque et cardiomyopathiesJESFC27-16913.67Malnutrition in patients hospitalized for heart failure using five nutritional scores: prevalence, clinical profile and prognostic implications: The HEARTNUTS study
02 - Insuffisance cardiaque et cardiomyopathiesJESFC27-47913.50A Strain-Based Risk Stratification Model for Early Detection of Cardiac Involvement in Systemic Sarcoidosis
02 - Insuffisance cardiaque et cardiomyopathiesJESFC27-63713.33"Battements Contraires": The Ligue contre la cardiomyopathie combines art and health to reveal invisible distress and humanize the care pathway
02 - Insuffisance cardiaque et cardiomyopathiesJESFC27-18513.33Age-distribution of vaccination uptake in adult heart failure patients: a cross-sectional telemonitoring survey
02 - Insuffisance cardiaque et cardiomyopathiesJESFC27-55213.33Association Between Obesity and NT-proBNP Levels in Very Old Adults Hospitalized for Heart Failure: A Cardiogeriatric Cohort Study
02 - Insuffisance cardiaque et cardiomyopathiesJESFC27-08113.33Early in-hospital initiation of dapagliflozin versus empagliflozin in acute heart failure: impact on in-hospital survival and safety
02 - Insuffisance cardiaque et cardiomyopathiesJESFC27-33113.33Epidemiology, presentation and short-term evolution of infections in LVAD recipients
02 - Insuffisance cardiaque et cardiomyopathiesJESFC27-22613.33Time-domain heart rate variability indices predict adverse outcomes in heart failure
02 - Insuffisance cardiaque et cardiomyopathiesJESFC27-05713.00Diaphragmatic dysfunction in acute heart failure : An Ultrasound-Based Analysis of muscle Thickness and Excursion
02 - Insuffisance cardiaque et cardiomyopathiesJESFC27-19113.00Guideline-directed heart failure pharmacotherapy in adults aged ≥75 years: evidence gaps, tolerability and implications for clinical practice
02 - Insuffisance cardiaque et cardiomyopathiesJESFC27-59613.00Heart failure telemonitoring in very elderly patients: a cardio-geriatric centre experience compared with a national cohort
02 - Insuffisance cardiaque et cardiomyopathiesJESFC27-08313.00Impact of early in-hospital SGLT2 inhibitor use on mortality in acute heart failure: a real-world cohort study
02 - Insuffisance cardiaque et cardiomyopathiesJESFC27-83413.00Peripartum cardiomyopathy in sub-saharan Africa: Clinical Profile and 6-Month Outcomes from a Prospective Congolese Registry
02 - Insuffisance cardiaque et cardiomyopathiesJESFC27-44813.00Survival and predictors of in-hospital mortality in patients followed for peripartum cardiomyopathy
02 - Insuffisance cardiaque et cardiomyopathiesJESFC27-18813.00Vaccine administration pathways in adult heart failure: a sex- and age-stratified analysis in a telemonitored cohort

Abstracts repêchés sous le seuil de 13 (5)

ThèmeRéf.NoteTitre
05 - Rythmologie et stimulation cardiaqueJESFC27-19512.67Impact of Continuous Positive Airway Pressure on Left Atrial Remodeling and Atrial Fibrillation Recurrence after voltage-guided ablation in Patients with Severe Obstructive Sleep Apnea
05 - Rythmologie et stimulation cardiaqueJESFC27-38512.67Residual Stroke Risk in Anticoagulated Atrial Fibrillation: Clinical Predictors of High-Risk Patients
07 - Recherche fondamentale & translationnelleJESFC27-05112.67Hemodynamic strategies in pediatric critical care unit: Ultrasound-Guided transition within the ROSE FrameworkP
07 - Recherche fondamentale & translationnelleJESFC27-48512.33Global Landscape of Cardiovascular Research: A Continental Bibliometric Analysis Standardized by Population and Physician Density
07 - Recherche fondamentale & translationnelleJESFC27-74012.00Acute impact of hemodialysis on left ventricular function assessed by speckle tracking echocardiography in pediatric end-stage renal disease

Validation du comité scientifique

À compléter par le référent médical scientifique après relecture des sessions ci-dessus.

Nom / fonction
Date de relecture
Sessions validées sans réserve☐ Oui    ☐ Non
Commentaires / modifications demandées